E. H. Pieter van Dijkhuizen

Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study

Alessandro Consolaro, Gabriella Giancane, Alessandra Alongi et al. · The Lancet Child & Adolescent Health · 2019 · 214 citations · Full text

Medicine, Child Health, Pediatrics +16

Treatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five‐Year Follow‐Up Study

Nienke M. ter Haar, E. H. Pieter van Dijkhuizen, Joost F. Swart et al. · Arthritis & Rheumatology · 2019 · 186 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: Development and validation of a methotrexate intolerance severity score

Maja Bulatović, Marloes W Heijstek, Marleen Verkaaik et al. · Arthritis & Rheumatism · 2011 · 180 citations

Medicine, Clinical Sciences, Pharmacotherapy +11

Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis

Chiara Trincianti, E. H. Pieter van Dijkhuizen, Alessandra Alongi et al. · Arthritis & Rheumatology · 2021 · 97 citations · Full text

Medicine, Clinical Sciences, Pediatrics +15

Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis

Joost F. Swart, E. H. Pieter van Dijkhuizen, Nico Wulffraat et al. · Annals of the Rheumatic Diseases · 2017 · 84 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +12